Sponsor:
University of South Florida
Code:
NCT04430179
Conditions
Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations